Skip to NavigationSkip to content

News

NICE, the UK’s drug watchdog for the NHS, has decided that Janssen’s Tremfya (guselkumab) should be used routinely through the health service in...
It’s been a week in which one of the largest pharmaceutical takeovers in history took place and yet it’s not the most talked about event of the week...
Roche has been rocked by a Phase 3 weak showing from its combination Tecentriq (atezolizumab) and Cotellic (cobimetinib) in people with heavily pre...
AstraZeneca’s Fasenra arrived later on the scene than GSK rival med, Nucala, and so it needed to quickly rack up indications to mount a serious...
This workshop, through plenary and parallel sessions, will focus on current challenging topics within the global pharmaceutical/biopharmaceutical...
Armo BioSciences only went public in January but it has already been snapped up by Eli Lilly for $1.6 billion. This marks a 68% premium on the...
At the request of the FDA, The US Department of Justice has launched legal action seeking to shut down stem cell clinics in California and Florida...
Lodo Therapeutics' form of drug discovery has managed to catch the eye of Roche’s subsidiary, Genentech, which has put down an undisclosed upfront...
Novartis payment to President Trump’s personal lawyer, Michael Cohen, had seemed fairly odd from the beginning – with many asking the same question,...
The revamped edition focuses on three key therapeutic areas: oncology, cardiovascular disease, and central nervous system disorders.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches